NeuroPace Inc (NPCE) income statement
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)
Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%
NeuroPace Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 79.6%
- Operating margin
- -15.3%
- Net margin
- -19.3%
- Return on equity, FY2025
- -158.7%
Financial strength
- Current ratio
- 4.94
- Debt to equity
- 4.97
- Debt to assets
- 60.8%
- Cash to current liabilities
- 71.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.85
- Price to book
- 23.74
- Dividend yield
- 0.00%
See a number that looks wrong?